$HUMA Income Statement | Understand Stock

$HUMA

$0.45 +$0.05 (11.41%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Grant revenue
Revenue
Product
Contract Revenue
Total revenue
Operating expenses:
Cost of goods sold
Product
Total cost of goods sold
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense), net
Interest income
Change in fair value of Contingent Earnout Liability
Interest expense
Change in fair value of derivatives
Employee retention credit
Loss on extinguishment of debt
Transaction costs expensed
Total other expense, net

Net loss and comprehensive loss
Comprehensive loss
Net loss per share attributable to common stockholders, basic (in dollars per share)
Net loss per share attributable to common stockholders, diluted (in dollars per share)
Weighted-average shares outstanding used in computing net loss per share attributable to common stockholders, basic (in shares)
Weighted-average shares outstanding used in computing net loss per share attributable to common stockholders, diluted (in shares)

Comments